IPOs, Chips, and Clinical AI: The Infrastructure Shift

Claire and Peter break down a packed day in AI as the story moves from flashy demos to capital, governance, and real-world deployment. They unpack SpaceX’s IPO filing and how AI investment, Musk-linked related-party ties, and control structures could reshape risk for partners—and what OpenAI’s reported IPO preparations might mean for enterprise contracts and pricing. Then they look at Washington’s proposed voluntary pre-release reviews for frontier models, Nvidia’s blowout quarter alongside its effective exit from China’s AI chip market, and Singtel’s push into sovereign GPU-as-a-Service. The episode also covers Intuit’s major restructuring, a milestone EU certification for an AI-native EHR platform, retail wins from cleaner product data pipelines, and a new Nature paper on AI systems that can build scientific software—faster than humans, with big implications for verification and safety.About Six & FlowSix & Flow is a digital transformation consultancy helping businesses adapt, grow, and thrive in a fast-changing world. We specialise in AI, CRM, and revenue operations, blending strategy, technology, and creativity to deliver measurable impact. From scaling startups to global enterprises, we partner with ambitious teams to unlock growth through smart automation, customer-centric marketing, and forward-thinking sales enablement. Learn more at sixandflow.com. Hosted on Acast. See acast.com/privacy for more information.